Lite Strategy (LITS) Receivables (2021 - 2023)
Lite Strategy (LITS) posted Receivables of $85000.0 for Q2 2023, down 99.15% on a QoQ basis from $10.0 million in Q2 2022, and down 99.15% year-over-year from $10.0 million in Q2 2022.
Analysis
Lite Strategy (LITS) Receivables (2021 - 2023) Analysis & Trends
Lite Strategy has reported Receivables for 3 years, with the latest figure at $85000.0 in Q2 2023.
- On a quarterly basis, Receivables fell 99.15% year-over-year to $85000.0 in Q2 2023; TTM through Jun 2023 was $85000.0, a 99.15% decrease from a year earlier, with the FY2023 full-year figure at $85000.0, down 99.15% from the prior year.
- Receivables was $85000.0 for Q2 2023 at Lite Strategy, down from $10.0 million in the prior quarter.
- The five-year high for Receivables was $18.1 million in Q3 2021, with the low at $85000.0 in Q2 2023.
- Average Receivables over 3 years is $9.0 million, with a median of $8.8 million recorded in 2021.
- The sharpest annual moves came in 2022 and 2023: Receivables jumped 32.47% in 2022, then sank 99.15% in 2023.
- Over 3 years, Receivables stood at $18.1 million in 2021, then plunged by 44.57% to $10.0 million in 2022, then tumbled by 99.15% to $85000.0 in 2023.
- The last three Receivables figures came in at $85000.0 (Q2 2023), $10.0 million (Q2 2022), and $18.1 million (Q3 2021), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 206.44 Bn | 192.45 Bn | 7.24 Bn | 10.23 Bn |
| 2 | Gilead Sciences | 179.97 Bn | 176.79 Bn | 6.22 Bn | 5.90 Bn |
| 3 | Vertex Pharmaceuticals | 130.57 Bn | 122.72 Bn | 2.84 Bn | 2.13 Bn |
| 4 | Regeneron Pharmaceuticals | 81.63 Bn | 73.63 Bn | 3.93 Bn | 6.57 Bn |
| 5 | Argenx Se | 60.34 Bn | 55.16 Bn | 1.37 Bn | 1.93 Bn |
| 6 | Moderna | 54.37 Bn | 49.23 Bn | 52.00 Mn | 160.00 Mn |
| 7 | Alnylam Pharmaceuticals | 33.07 Bn | 29.76 Bn | 992.69 Mn | 912.74 Mn |
| 8 | Biogen | 31.84 Bn | 30.55 Bn | 1.96 Bn | 1.89 Bn |
| 9 | Roivant Sciences | 29.49 Bn | 29.49 Bn | 1.16 Mn | - |
| 10 | Lite Strategy | 38.03 Mn | 30.49 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2023 | 85,000.00 |
| Jun 30, 2022 | 10.04 Mn |
| Sep 30, 2021 | 18.12 Mn |
| Jun 30, 2021 | 7.58 Mn |